TNF Pharmaceuticals Inc. (TNFA)
TNF Pharmaceuticals Statistics
Share Statistics
TNF Pharmaceuticals has 2.76M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 2.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 5K |
| FTD / Avg. Volume | 0.5% |
Short Selling Information
The latest short interest is 267.35K, so 9.7% of the outstanding shares have been sold short.
| Short Interest | 267.35K |
| Short % of Shares Out | 9.7% |
| Short % of Float | 10.21% |
| Short Ratio (days to cover) | 6.39 |
Valuation Ratios
The PE ratio is -0.74 and the forward PE ratio is null. TNF Pharmaceuticals's PEG ratio is 0.01.
| PE Ratio | -0.74 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.23 |
| P/FCF Ratio | -0.23 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for TNF Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.
| Current Ratio | 1.17 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-666.66K |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 2.48, so TNF Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 2.48 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 29.85 |
| Average Volume (20 Days) | 1M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -17.12M |
| Net Income | -4M |
| EBITDA | -4M |
| EBIT | -16.36M |
| Earnings Per Share (EPS) | -5.33 |
Balance Sheet
The company has 2.68M in cash and 48.87K in debt, giving a net cash position of 2.63M.
| Cash & Cash Equivalents | 2.68M |
| Total Debt | 48.87K |
| Net Cash | 2.63M |
| Retained Earnings | -101.98M |
| Total Assets | 24.04M |
| Working Capital | 5.04M |
Cash Flow
In the last 12 months, operating cash flow was -12.98M and capital expenditures 5, giving a free cash flow of -12.98M.
| Operating Cash Flow | -12.98M |
| Capital Expenditures | 5 |
| Free Cash Flow | -12.98M |
| FCF Per Share | -8.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNFA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for TNFA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 15, 2024. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 15, 2024 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -8.33 |
| Piotroski F-Score | 2 |